OraSure Technologies, Inc. recalls Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical labo

Recalled December 14, 2016 · FDA recall Z-0722-2017 · OraSure Technologies

Hazard

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing. · FDA Class III

Units

4 kits

Sold at

Distributed to KS, and VA

Description

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

Product

Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.

Manufacturer(s)

OraSure Technologies, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →